EDGAR Filing Documents for 0001193125-12-117326

Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]:

SEC Accession No. 0001193125-12-117326

Filing Date

2012-03-15

Accepted

2012-03-15 16:08:51

Documents

Period of Report

2011-12-31

Document Format Files

Seq	Description	Document	Type	Size
1	FORM 10-K	d238298d10k.htm	10-K	936825
2	AMENDMENT NO. 1 TO RIGHTS AGREEMENT	d238298dex47.htm	EX-4.7	12662
3	CONSENT OF OUM & CO., LLP	d238298dex231.htm	EX-23.1	1522
4	CERTIFICATION OF THE PRINCIPAL EXEC AND FIN OFFICER PURSUANT TO RULE 13(A)-14(A)	d238298dex311.htm	EX-31.1	8489
5	CERTIFICATE OF THE PRINCIPAL EXEC AND FIN OFFICER PURSUANT TO SECTION 906	d238298dex321.htm	EX-32.1	3632
12	GRAPHIC	g238298g23a92.jpg	GRAPHIC	41629
	Complete submission text file	0001193125-12-117326.txt		2877678

Data Files

Seq	Description	Document	Type	Size
6	XBRL INSTANCE DOCUMENT	ttnp-20111231.xml	EX-101.INS	343736
7	XBRL TAXONOMY EXTENSION SCHEMA	ttnp-20111231.xsd	EX-101.SCH	15223
8	XBRL TAXONOMY EXTENSION CALCULATION LINKBASE	ttnp-20111231_cal.xml	EX-101.CAL	32313
9	XBRL TAXONOMY EXTENSION DEFINITION LINKBASE	ttnp-20111231_def.xml	EX-101.DEF	11467
10	XBRL TAXONOMY EXTENSION LABEL LINKBASE	ttnp-20111231_lab.xml	EX-101.LAB	127875
11	XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE	ttnp-20111231_pre.xml	EX-101.PRE	86973

Mailing Address 400 OYSTER POINT BLVD SUITE 505 SAN FRANCISCO CA 94080

Business Address 400 OYSTER POINT BLVD SUITE 505 SAN FRANCISCO CA 94080 4152444990

TITAN PHARMACEUTICALS INC (Filer) CIK: 0000910267 (see all company filings)